Skip to Main Content

Paper Details

Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction.
Nat Commun
364
2015
FXR, Fxr, GW4064, Gly-MCA, beige fat, bile acid, ceramide, farnesoid, farnesoid X receptor, glycine--muricholic acid, hepatic steatosis, humans, insulin, insulin resistance, intestine, metabolic disorders, mice, mouse, obese, obesity
Author NameAffiliation
William H BissonOregon State University
Frank J GonzalezCenter for Cancer Research, National Cancer Institute, National Institutes of Health
  • 1 - 2

Datasets

Release 1.2